Stress-related hormonal suppression of natural killer activity does not show menstrual cycle variations: Implications for timing of surgery for breast cancer

Anticancer Research

Volumn 23, Issue 3 B, 2003, Pages 2531-2535

  Garland, Malcolm ^a,b,d   Doherty, Derek ^c   Golden Mason, Lucy ^a,b   Fitzpatrick, Patricia ^b   Walsh, Noel ^a   O'Farrelly, Cliona ^a,b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^d BEAUMONT HOSPITAL   (Ireland)

Author keywords

Adrenaline; Breast cancer; Cortisol; Menstrual cycle; NK cell activity; NK cells

Indexed keywords

ADRENALIN; CHROMIUM 51; HYDROCORTISONE;

ADULT; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER SURVIVAL; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; FOLLICULAR PHASE; HORMONAL REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUTEAL PHASE; MENSTRUAL CYCLE; MONONUCLEAR CELL; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; SURGICAL STRESS; TIME SERIES ANALYSIS;

ADULT; BREAST NEOPLASMS; CELL COUNT; EPINEPHRINE; FEMALE; FLOW CYTOMETRY; FOLLICULAR PHASE; HUMANS; HYDROCORTISONE; KILLER CELLS, NATURAL; LUTEAL PHASE;

EID: 0042306468     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cooper LS, Gillet CE, Patel NK, Barnes DM and Fentiman IS: Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and oestrogen receptor/progesterone receptor status of the primary tumor. Cancer 86(10): 2053-2058, 1999.
2. Anderson E, Clarke RB and Howell A: Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia 3(1): 23-35, 1998.
3. Veronesi U, Luini A, Mariani L, Del Vecchio M, Alvez D, Andreoli C, Giacobone A, Merson M, Pacetti G, Raselli R et al: Effect of menstrual phase on surgical treatment of breast cancer. Lancet 343(8912): 1545-1547, 1994.
4. Heer K, Kumar H, Speirs V, Greenman J, Drew PJ, Fox JN, Carleton PJ, Monson, JR and Kerin MJ: Vascular endothelial growth factor in premenopausal women-indicator of the best time for breast cancer surgery? Br J Cancer 78(9): 1203-1207, 1998.
5. Saad Z, Bramwell VH, Wilson SM, O'Malley FP, Jeacock J and Chambers AF: Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases. Lancet 351 (9110): 1170-1173, 1998.
6. Brittenden J, Heys SD, Ross J and Eremin O: Natural killer cells and cancer. Cancer 77: 1226-1243, 1996.
7. Cohen JH, Danel L, Cordier G, Saez S and Revillard JP: Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of oestrogen receptors to OKT8-positive cells. J Immunol 131(6): 2767-2771, 1983.
8. Armanini D, Endres S, Kuhnle U and Weber PC: Parallel determination of mineralocorticoid and glucocorticoid receptors in T- and B-lymphocytes of human spleen. Acta Endocrinol 118(4): 479-482, 1988.
9. Sanders V, Kasprovwicz D, Kohm AP and Swanson MA: Neurotransmitter receptors on lymphocytes and other lymphoid cells. In: Psychoneuroimmunology. (Ader R, Felten DL and Cohen N, eds). New York, Academic Press 2001, pp 161-197.
10. Lopez-Karpovitch X, Larrea F, Cardenas R, Valencia X, Piedras J, Diaz-Sanchez V and Alarcon-Segovia D: Peripheral blood lymphocyte subsets and serum immunoglobulins in Sheehan's syndrome and in normal women during the menstrual cycle. Rev Invest Clin 45(3): 247-53, 1993.
11. Sulke AN, Jones DB and Wood PJ: Variation in natural killer activity in peripheral blood during the menstrual cycle. Br Med J 290 (6472): 884-886, 1985.
12. Pross HF and Maroun JA: The standardization of NK cell assays for use in studies of biological response modifiers. J Immunol Methods 68(1-2): 235-49, 1984.
13. Fujiwara S, Akiyama M, Yamakido M, Seyama T, Kobuke K, Hakoda M, Kyoizumi S and Jones SL: Cryopreservation of human lymphocytes for assessment of lymphocyte subsets and natural killer cytotoxicity. J Immunol Methods 90(2): 265-273, 1986.
14. Bryant J, Day R, Whiteside TL and Herberman RB: Calculation of lytic units for the expression of cell-mediated cytotoxicity. J Immunol Methods 146(1): 91-103, 1992.
15. Paavonen T: Hormonal regulation of immune responses. Ann Med 26(4): 255-258, 1994.
16. Flynn L, Byrne B, Carton J, Kelehan P, O'Herlihy C and O'Farrelly C: Menstrual cycle dependent fluctuations in NK and T-lymphocyte subsets from non-pregnant human endometrium. Am J Reprod Immunol 43(4): 209-217, 2000.
17. Gonik B, Loo LS, Bigelow R and Kohl S: Influence of menstrual cycle variations on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity to cells infected with herpes simplex virus. J Reprod Med 30(6): 493-496, 1985.
18. Thyss A, Caldani C, Bourcier C, Benita G and Schneider M: Comparison of natural killer activity during the first and second halves of the menstrual cycle in women [Letter]. Br J Cancer 50(1): 127-128, 1984.
19. Shakhar K, Shakhar G, Rosenne E and Ben-Eliyahu S: Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity. Br J Cancer 83(12): 1630-16366, 2000.
20. Irwin M: Psychoneuroimmunology of depression. In: Psychopharmacology, The Fourth Generation of Progress (FE Bloom and DJ Kupfer, eds). New York, Raven Press. 1995, pp 983-987.